JAMA Intern Med:我国多中心随机研究:针灸可减轻稳定心绞痛患者症状

2019-07-31 xujing 中国循环杂志

近期,JAMA内科学子刊上发表我国成都中医药大学的一项针灸的多中心随机研究。

近期,JAMA内科学子刊上发表我国成都中医药大学的一项针灸的多中心随机研究。

结果表明,在标准的抗心绞痛治疗基础上,针灸可减轻慢性稳定型心绞痛患者的心绞痛症状,减少心绞痛频率和疼痛强度。

作者认为,这是最大规模有关针灸辅助治疗慢性稳定型心绞痛的多中心临床试验,证实针灸的有效性,并且也探讨了针灸治疗心绞痛的穴位。

研究以中医辨证论治为基础,选择位于心包经络的PC6和位于心经络的HT5作为针灸穴位。


图1 三个治疗组的针刺点

将受试者随机分至治疗穴位针灸组、非治疗穴针灸组、假针灸组或没有针灸的对照组,前3组受试者每周针灸3次,共4周。

患者每天记录心绞痛发作次数。主要终点为从基线到第16周期间每4周心绞痛发作频率的变化。

研究发现,每周对疾病相关经络的穴位进行三次针灸治疗,每次30分钟。在减少心绞痛发作方面优于非治疗穴位针灸组、假针灸组和对照组。

此外,针灸也改善了6分钟步行距离、加拿大心血管学会心绞痛分级以及西雅图心绞痛问卷的大多数指标,并在治疗后12周患者的焦虑和抑郁症状得到减轻。


图 2  研究期间各组的心绞痛发作频率

此外,研究还发现,与对照组和假针灸组相比,针对治疗穴位的针灸可改善焦虑和抑郁。

作者认为,针对治疗穴位的针灸可改善治疗期间迷走神经和交感神经系统之间的平衡。

根据ACC/AHA标准,在中国五个医疗中心纳入404例慢性稳定型心绞痛患者,均接受了基于指南的抗心绞痛治疗,但仍每周至少出现两次心绞痛。

所有患者都接受心绞痛的药物治疗,包括β受体阻滞剂、阿司匹林、他汀类药物和血管紧张素转换酶抑制剂等。

原始出处:Zhao L1, Li D2, Zheng H1, et al. Acupuncture as Adjunctive Therapy for Chronic Stable Angina: A Randomized Clinical Trial. JAMA Intern Med. 2019 Jul 29. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903991, encodeId=fae91903991cd, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Dec 02 08:58:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043156, encodeId=3cde20431563a, content=<a href='/topic/show?id=3972e5296e6' target=_blank style='color:#2F92EE;'>#稳定心绞痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75296, encryptionId=3972e5296e6, topicName=稳定心绞痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Sun Sep 29 04:58:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941976, encodeId=38b019419e683, content=<a href='/topic/show?id=338b98462fa' target=_blank style='color:#2F92EE;'>#随机研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98462, encryptionId=338b98462fa, topicName=随机研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sun Jul 12 13:58:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370691, encodeId=5bbc3e069192, content=能否减少心肌梗塞等事件的发生?, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7651573043, createdName=lthzgl, createdTime=Sat Aug 03 07:59:41 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609899, encodeId=f1c81609899de, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 02 12:58:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370590, encodeId=e4453e059096, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Aug 01 05:52:24 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1903991, encodeId=fae91903991cd, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Dec 02 08:58:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043156, encodeId=3cde20431563a, content=<a href='/topic/show?id=3972e5296e6' target=_blank style='color:#2F92EE;'>#稳定心绞痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75296, encryptionId=3972e5296e6, topicName=稳定心绞痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Sun Sep 29 04:58:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941976, encodeId=38b019419e683, content=<a href='/topic/show?id=338b98462fa' target=_blank style='color:#2F92EE;'>#随机研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98462, encryptionId=338b98462fa, topicName=随机研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sun Jul 12 13:58:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370691, encodeId=5bbc3e069192, content=能否减少心肌梗塞等事件的发生?, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7651573043, createdName=lthzgl, createdTime=Sat Aug 03 07:59:41 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609899, encodeId=f1c81609899de, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 02 12:58:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370590, encodeId=e4453e059096, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Aug 01 05:52:24 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1903991, encodeId=fae91903991cd, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Dec 02 08:58:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043156, encodeId=3cde20431563a, content=<a href='/topic/show?id=3972e5296e6' target=_blank style='color:#2F92EE;'>#稳定心绞痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75296, encryptionId=3972e5296e6, topicName=稳定心绞痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Sun Sep 29 04:58:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941976, encodeId=38b019419e683, content=<a href='/topic/show?id=338b98462fa' target=_blank style='color:#2F92EE;'>#随机研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98462, encryptionId=338b98462fa, topicName=随机研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sun Jul 12 13:58:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370691, encodeId=5bbc3e069192, content=能否减少心肌梗塞等事件的发生?, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7651573043, createdName=lthzgl, createdTime=Sat Aug 03 07:59:41 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609899, encodeId=f1c81609899de, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 02 12:58:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370590, encodeId=e4453e059096, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Aug 01 05:52:24 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1903991, encodeId=fae91903991cd, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Dec 02 08:58:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043156, encodeId=3cde20431563a, content=<a href='/topic/show?id=3972e5296e6' target=_blank style='color:#2F92EE;'>#稳定心绞痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75296, encryptionId=3972e5296e6, topicName=稳定心绞痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Sun Sep 29 04:58:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941976, encodeId=38b019419e683, content=<a href='/topic/show?id=338b98462fa' target=_blank style='color:#2F92EE;'>#随机研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98462, encryptionId=338b98462fa, topicName=随机研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sun Jul 12 13:58:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370691, encodeId=5bbc3e069192, content=能否减少心肌梗塞等事件的发生?, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7651573043, createdName=lthzgl, createdTime=Sat Aug 03 07:59:41 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609899, encodeId=f1c81609899de, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 02 12:58:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370590, encodeId=e4453e059096, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Aug 01 05:52:24 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2019-08-03 lthzgl

    能否减少心肌梗塞等事件的发生?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1903991, encodeId=fae91903991cd, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Dec 02 08:58:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043156, encodeId=3cde20431563a, content=<a href='/topic/show?id=3972e5296e6' target=_blank style='color:#2F92EE;'>#稳定心绞痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75296, encryptionId=3972e5296e6, topicName=稳定心绞痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Sun Sep 29 04:58:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941976, encodeId=38b019419e683, content=<a href='/topic/show?id=338b98462fa' target=_blank style='color:#2F92EE;'>#随机研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98462, encryptionId=338b98462fa, topicName=随机研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sun Jul 12 13:58:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370691, encodeId=5bbc3e069192, content=能否减少心肌梗塞等事件的发生?, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7651573043, createdName=lthzgl, createdTime=Sat Aug 03 07:59:41 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609899, encodeId=f1c81609899de, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 02 12:58:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370590, encodeId=e4453e059096, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Aug 01 05:52:24 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1903991, encodeId=fae91903991cd, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Dec 02 08:58:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043156, encodeId=3cde20431563a, content=<a href='/topic/show?id=3972e5296e6' target=_blank style='color:#2F92EE;'>#稳定心绞痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75296, encryptionId=3972e5296e6, topicName=稳定心绞痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Sun Sep 29 04:58:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941976, encodeId=38b019419e683, content=<a href='/topic/show?id=338b98462fa' target=_blank style='color:#2F92EE;'>#随机研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98462, encryptionId=338b98462fa, topicName=随机研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sun Jul 12 13:58:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370691, encodeId=5bbc3e069192, content=能否减少心肌梗塞等事件的发生?, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7651573043, createdName=lthzgl, createdTime=Sat Aug 03 07:59:41 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609899, encodeId=f1c81609899de, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 02 12:58:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370590, encodeId=e4453e059096, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Aug 01 05:52:24 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2019-08-01 yjs木玉

    好好好好好好

    0

相关资讯

[重复]中国针灸有望纳入美国医保?能治四百多种病

近日,美国总统特朗普签署一项名为H.R.6的法案,旨在寻找治疗疼痛的替代性药物和疗法,遏制阿片类止痛药物在美国的泛滥。在该法案中,针灸、医疗按摩等项目,被列入有待评估的替代性疗法。这意味着,未来一年内,针灸有望获美国卫生部评估和认可。阿片类药物滥用成瘾 针灸大有可为目前,美国阿片类止痛药物滥用与成瘾危机日益严重,阿片类止痛药包括杜冷丁、吗啡等,镇痛作用强大,但有极强成瘾性。官方数据显示,每天平均有

Medicine (Baltimore):针灸在过敏性鼻炎患者中的治疗效果研究

最近,有研究人员在舌下特异性过敏原免疫治疗(SASIT)的过敏性鼻炎(AR)患者中,回顾性的分析了针灸疗法作为一种附加的疗法(AAOT)对过敏性鼻炎患者的治疗效果。研究总共包括了120名符合研究标准的AR成年人患者。其中60名患者接受了AAOT和SASIT治疗,并作为治疗组,其他60名受试者只接受了SASIT治疗,并作为对照组。主要结果为AR症状,次级结果为通过鼻炎生活质量调查问卷(RQLQ)评估

男子针灸时呼吸困难,不幸身亡!死因令人心惊

平时身体有点不舒服,有些人喜欢做做针灸、拔罐。近日,张家口一男子在养生店针灸、拔罐时突然呼吸困难、脸色发黑,最终抢救无效死亡。2019年7月5日,张家口市公安局下花园分局就此事发布通报。2019年6月18日,崔某因身体不适,在妻子的陪同到张家口下花园五谷膳食养生店进行针灸理疗,店主康某先后为崔某针灸、拔罐,过程中崔某呼吸困难,脸色发黑,病情愈加严重,康某见状将其送往医院,后崔某抢救无效死亡。案件发

针灸竟针出椎管内血肿?

随着职业及生活方式的改变,现在越来越多人会有腰背痛的症状。其中很多人喜欢到中医养生馆这些地方做“推拿”、“针灸”,以此希望能够缓解腰背痛症状。对于推拿、针灸,我们又该注意些什么呢?

Neurology:针灸后可见皮肤部位脑脊液漏出

针灸在亚洲国家广泛使用。27岁男性,因新近出现的直立性头痛就诊。数周前,患者腰背部(L3-S1)行多次重复针灸,以缓解过去几年椎板切除和椎间融合(L4-S1)术后仍然存在的疼痛。

中国针灸有望纳入美国医保?四百多种病针灸都能治

近日,美国总统特朗普签署一项名为H.R.6的法案,旨在寻找治疗疼痛的替代性药物和疗法,遏制阿片类止痛药物在美国的泛滥。在该法案中,针灸、医疗按摩等项目,被列入有待评估的替代性疗法。这意味着,未来一年内,针灸有望获美国卫生部评估和认可。阿片类药物滥用成瘾 针灸大有可为目前,美国阿片类止痛药物滥用与成瘾危机日益严重,阿片类止痛药包括杜冷丁、吗啡等,镇痛作用强大,但有极强成瘾性。官方数据显示,每天平均有